Based on the Advanced Human Imaging stock forecast from 0 analysts, the average analyst AHI stock price target is $11 over the next 12 months. Advanced Human Imaging Ltd ADR’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AHI stock is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Advanced Human Imaging stock price was USD 1.32. Advanced Human Imaging stock price has changed by +0.73% over the past week, +0.82% over the past month and +0.00% over the last year.
About Advanced Human Imaging Ltd. ADR (AHI:NSD):
Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.
What we like:
There is nothing we particularly like about Advanced Human Imaging stock.
What we don’t like:
Low market capitalization:
AHI stock is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow:
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth:
AHI stock has shown below median earnings growth in the previous 5 years compared to its sector
Low Revenue Growth:
AHI stock has shown below median revenue growth in the previous 5 years compared to its sector
Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.